J. Scott Wolchko, President and CEO at FATE THERAPEUTICS INC (FATE), sold 100,000 shares at $20.08 ($2.0M) on 2019-12-19, disclosed to the SEC on 2019-12-23.
Open-market sale of $2.0M FATE by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.08 | 25,000 | $502K | 24.9% |
| 2 | $20.08 | 25,000 | $502K | 24.9% |
| 3 | $20.17 | 25,000 | $504K | 25.1% |
| 4 | $20.17 | 25,000 | $504K | 25.1% |
| Total | $20.13 avg | 100,000 | $2.0M | 100% |
| Filing → |
| FATE | SELL | 2022-07-25 | $2.4M | — | Filing → |
| FATE | SELL | 2022-04-25 | $2.6M | — | Filing → |
| FATE | SELL | 2022-01-24 | $2.0M | — | Filing → |